Abstract
Background/AimsLevosimendan is an inotropic and vasodilator drug. Most protocols suggest avoiding other vasodilators, inodilators after its introduction. The technical data recommends not using with other vasodilators. We report our experience...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have